Related Articles
EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab
EGFRvIII mutation in lung cancer correlates with increased EGFR copy number
Cetuximab treatment for metastatic colorectal cancer with KRAS p.G13D mutations improves progression-free survival
Predictive and prognostic factors in second- and third-line erlotinib treatment in NSCLC patients with known status of the EGFR gene
Association between EGFR exon 19 or exon 21 mutations and survival rates after first‑line EGFR‑TKI treatment in patients with non‑small cell lung cancer